Details for 2015835924

Up to date per 01.04.2026

Actions

Title / Product Name

PATISIRAN ZUR BEHANDLUNG VON TRANSTHYRETIN-VERMITTELTER AMYLOIDOSE

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2015835924

EP Publication Number

3185957

E-Number

1494925

Language

PCT Number

US15047185

Publication Date

05.07.2017 A

01.06.2022 B1

Registration Date

01.06.2022

AT Publication Date

15.06.2022

Application Date

27.08.2015

Registration Number

Priorities

29.08.2014

201462044100 P

21.04.2015

201562150596 P

IPC

A61K 31/573 20060101AFI20211203BHEP

Maximum Duration of Protection

27.08.2035

Owner

Alnylam Pharmaceuticals, Inc.675 West Kendall Street, Henri A, Termeer Square Cambridge, MA 02142US

Representative

Dipl.-Ing. Dr. techn. Elisabeth SchoberBrigittenauer Lände 501200 WIENAT

Inventor

BETTENCOURT, Brian Cambridge, MA 02142US

Information about Fees